Pharma industry’s next big leap
The year was 2013. The breakthrough Hepatitis C drug sofosbuvir entered the US market at about $1,000 per tablet, placing treatment beyond the reach of many patients. Bangladesh, however, took advantage of the World Trade Organization’s TRIPS waiver for …